These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1133 related articles for article (PubMed ID: 29290580)

  • 1. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.
    Mercuri E; Finkel RS; Muntoni F; Wirth B; Montes J; Main M; Mazzone ES; Vitale M; Snyder B; Quijano-Roy S; Bertini E; Davis RH; Meyer OH; Simonds AK; Schroth MK; Graham RJ; Kirschner J; Iannaccone ST; Crawford TO; Woods S; Qian Y; Sejersen T;
    Neuromuscul Disord; 2018 Feb; 28(2):103-115. PubMed ID: 29290580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for the diagnosis and management of typical childhood spinal muscular atrophy.
    Cuisset JM; Estournet B;
    Rev Neurol (Paris); 2012 Dec; 168(12):902-9. PubMed ID: 23107878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmenting the SMN Protein to Treat Infantile Spinal Muscular Atrophy.
    Kim JK; Monani UR
    Neuron; 2018 Mar; 97(5):1001-1003. PubMed ID: 29518354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile spinal muscular atrophy (SMA).
    Chabrol B; Desguerre I
    Arch Pediatr; 2020 Dec; 27(7S):7S1-7S2. PubMed ID: 33357590
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional and surgical treatments in patients with spinal muscular atrophy (SMA).
    Boulay C; Peltier E; Jouve JL; Pesenti S
    Arch Pediatr; 2020 Dec; 27(7S):7S35-7S39. PubMed ID: 33357596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of T274I mutation in the SMN1 gene in a patient with spinal muscular atrophy].
    Jedrzejowska M; Wiszniewski W; Ryniewicz B; Hausmanowa-Petrusewicz I
    Med Wieku Rozwoj; 2002; 6(4):319-27. PubMed ID: 12810984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive epidemiology of spinal muscular atrophy type I in Estonia.
    Vaidla E; Talvik I; Kulla A; Kahre T; Hamarik M; Napa A; Metsvaht T; Piirsoo A; Talvik T
    Neuroepidemiology; 2006; 27(3):164-8. PubMed ID: 17035693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood spinal muscular atrophy: controversies and challenges.
    Mercuri E; Bertini E; Iannaccone ST
    Lancet Neurol; 2012 May; 11(5):443-52. PubMed ID: 22516079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of spinal muscular atrophy (SMA) type 2.
    Cancès C; Richelme C; Barnerias C; Espil C
    Arch Pediatr; 2020 Dec; 27(7S):7S18-7S22. PubMed ID: 33357592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Japanese Patients With SMA Type 1 Suggest that Axonal-SMN May Not Modify the Disease Severity.
    Yamada H; Nishida Y; Maihara T; Sa'adah N; Harahap NI; Nurputra DK; Ar Rochmah M; Nishimura N; Saito T; Kubo Y; Saito K; Nishio H
    Pediatr Neurol; 2015 Jun; 52(6):638-41. PubMed ID: 25838041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal muscular atrophy: a time for screening.
    Prior TW
    Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A paucisymptomatic neuromuscular disease mimicking type III 5q-SMA with complex rearrangements in the SMN gene.
    Lohkamp LN; von Au K; Goebel HH; Kress W; Grieben U; Drossel K; Garbes L; Wirth B; Heppner FL; Stenzel W
    J Child Neurol; 2014 Feb; 29(2):254-9. PubMed ID: 24334346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raising obstetricians' awareness of spinal muscular atrophy: towards early detection and reproductive planning.
    Parra J; Tizzano EF
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2555-8. PubMed ID: 22712688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal muscular atrophy.
    Iannaccone ST
    Semin Neurol; 1998; 18(1):19-26. PubMed ID: 9562664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal muscular atrophy diagnostics.
    Prior TW
    J Child Neurol; 2007 Aug; 22(8):952-6. PubMed ID: 17761649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of "the consensus statement for the standard of care in spinal muscular atrophy" when applied to infants with severe type 1 SMA in the UK.
    Roper H; Quinlivan R;
    Arch Dis Child; 2010 Oct; 95(10):845-9. PubMed ID: 19819869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1.
    Al-Zaidy SA; Mendell JR
    Pediatr Neurol; 2019 Nov; 100():3-11. PubMed ID: 31371124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and developing therapies in spinal muscular atrophy.
    Kariyawasam D; Carey KA; Jones KJ; Farrar MA
    Paediatr Respir Rev; 2018 Sep; 28():3-10. PubMed ID: 29703692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular diagnosis of spinal muscular atrophy.
    Panigrahi I; Kesari A; Phadke SR; Mittal B
    Neurol India; 2002 Jun; 50(2):117-22. PubMed ID: 12134171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal muscular atrophy patient detection and carrier screening using dried blood spots on filter paper.
    Harahap NI; Harahap IS; Kaszynski RH; Nurputra DK; Hartomo TB; Pham HT; Yamamoto T; Morikawa S; Nishimura N; Rusdi I; Widiastuti R; Nishio H
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):123-9. PubMed ID: 21942573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.